Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Kalydeco Passed FDA’s Approval Test With The Help Of A Failed Study

Jun 19 2012

• By Sue Sutter

Related Content

Innovative Drug Development: Kalydeco Provides A Paradigm, FDA’s Spielberg Says

Feb 20 2012

Secondary Endpoints Backed <em>Kalydeco</em>’s Efficacy, Despite Lack Of Correlation With Pulmonary Function

Jun 19 2012

<em>Kalydeco</em> Clinical Development

Jun 19 2012

Vertex Gets Quick FDA Approval Of Kalydeco; Prices New CF Drug At $294,000 Per Year

Jan 31 2012

Related Companies

Vertex Pharmaceuticals Incorporated

Additional Topics

United States Personalized Medicine BioPharmaceutical

More from United States

More from North America

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window